About this trial
According to the literature the lateral part of the Orbito Frontal Cortex (lOFC) is a relevant bilateral target for repetitive Trans-cranial Magnetic Stimulation (rTMS) in Obsessive Compulsive Disorder (OCD). Both hemispheres are concerned in terms of target.
Eligibility criteria
Qualifiers
Age: Participants will be both males and females, 18-65 years of age included.
diagnosis of OCD
all the patients must have failed to respond to at least two different pharmacological treatment used for at least 6 weeks
Affiliation to a social security system (recipient or assignee),
Disqualifiers
The exclusion criteria are a diagnosis of another psychiatric disorder (except for anxious disorders), a diagnosis of a significant active medical illness, pregnancy or other neurological illness
In accordance with the safety criteria for rTMS, patients with a history of seizure or bearing pacemakers, mobile metal implants, implanted medical pumps, or metal clips placed inside the skull will also be excluded
The patients won't be allowed to change their medication during the trial. The treatment must be stable at least 3 week before day 0.
Female subject who is pregnant, or of child-bearing age, sexually active and not using reliable contraception or who is nursing,
Trial design
Treatments tested in this trial
- rTMS Treatment